Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
916.25
-10.90 (-1.18%) Natco Pharma - Quaterly Results
Date: 09-02-2023
The sales is pegged at Rs. 4130.00 millions for the December 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 5295.00 millions during the year-ago period.Profit after Tax for the quarter ended December 2022 saw a decline of -47.91% from Rs. 716.00 millions to Rs. 373.00 millions.Operating Profit reported a sharp decline to 861.00 millions from 1193.00 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
| Sales | 4130.00 | 5295.00 | -22.00 | 15698.00 | 12537.00 | 25.21 | 17678.00 | 16535.00 | 6.91 |
| Other Income | 186.00 | 316.00 | -41.14 | 680.00 | 842.00 | -19.24 | 946.00 | 1011.00 | -6.43 |
| PBIDT | 861.00 | 1193.00 | -27.83 | 5850.00 | 3349.00 | 74.68 | 3076.00 | 5187.00 | -40.70 |
| Interest | 30.00 | 41.00 | -26.83 | 74.00 | 91.00 | -18.68 | 133.00 | 113.00 | 17.70 |
| PBDT | 831.00 | 1152.00 | -27.86 | 5776.00 | 3258.00 | 77.29 | 2943.00 | 5074.00 | -42.00 |
| Depreciation | 381.00 | 355.00 | 7.32 | 1133.00 | 1028.00 | 10.21 | 1384.00 | 1152.00 | 20.14 |
| PBT | 450.00 | 797.00 | -43.54 | 4643.00 | 2230.00 | 108.21 | 1559.00 | 3922.00 | -60.25 |
| TAX | 77.00 | 81.00 | -4.94 | 813.00 | 226.00 | 259.73 | 168.00 | 827.00 | -79.69 |
| Deferred Tax | -3.00 | -61.00 | -95.08 | -19.00 | -171.00 | -88.89 | -157.00 | -106.00 | 48.11 |
| PAT | 373.00 | 716.00 | -47.91 | 3830.00 | 2004.00 | 91.12 | 1391.00 | 3095.00 | -55.06 |
| Equity | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 |
| PBIDTM(%) | 20.85 | 22.53 | -7.47 | 37.27 | 26.71 | 39.51 | 17.40 | 31.37 | -44.53 |